GlassScriptPhysician profile
Mary Cairnie
NPI 1205205408
$3,701.08
in general payments reported to CMS, 2019-2025
17 companies · $300 in 2025
The $300 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,728 · 2020: $227 · 2022: $61.72 · 2023: $312 · 2024: $72.21 · 2025: $300.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $684.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $683.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $829.53 | 2019-2025 | Tecnis Iol |
| Sun Pharmaceutical Industries INC. | $508.77 | 2019-2025 | Cequa |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $475.35 | 2019-2020 | |
| Allergan, INC. | $401.89 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $290.35 | 2019-2020 | |
| Shire North American Group INC | $257.37 | 2019 | |
| Eyevance Pharmaceuticals LLC | $227.22 | 2019 | |
| Lumenis Be INC | $221.63 | 2023 | M22 |
| Alcon Vision LLC | $191.60 | 2025 | Rocklatan, Eysuvis |
| Carl Zeiss Meditec, INC. | $125.00 | 2019 | |
| Abbvie INC. | $42.08 | 2022-2023 | Vuity, Alphagan P, Lumigan |
| Oyster Point Pharma, INC. | $34.53 | 2024 | Tyrvaya |
| Merz North America, INC. | $27.67 | 2019 | |
| Omeros Corporation | $20.24 | 2019 | |
| Sight Sciences, INC. | $18.66 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Thea Pharma INC. | $17.89 | 2025 | Iyuzeh |
| Aerie Pharmaceuticals, INC. | $11.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Cairnie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.